SK pharmteco Showcases Global CDMO Manufacturing at CPHI
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
Mequon, Wisconsin, August 17, 2026 Vector Science and Therapeutics Corp. has entered into an amended and restated exclusive license...
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...
WAYNE, PENNSYLVANIA | January 2, 2026 — Ecovyst Inc. announced the completion of the sale of its Advanced Materials...
DUBLIN, Ireland, November 7, 2025 — Smurfit WestRock, a global leader in sustainable packaging, has inaugurated the world’s first...
Norwood, Massachusetts – October 31, 2025 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), an oncology and obesity-focused biotechnology company,...
TOKYO, Japan – October 31, 2025 — Nxera Pharma Co., Ltd. announced that its subsidiary, Nxera Pharma Japan, has...
